Moderna Inc (MRNA)

Payables turnover

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Cost of revenue (ttm) US$ in thousands 7,148,000 7,416,000 6,111,000 6,640,000 6,828,000 5,597,000 5,109,000 4,388,000 3,373,000 2,119,981 1,278,890 444,624 198,811 135,765 115,044 106,833 109,929 234,423
Payables US$ in thousands 520,000 494,000 310,000 389,000 487,000 330,000 181,000 199,000 302,000 87,000 77,000 8,000 18,000 20,521 18,817 11,034 7,090 11,737 29,609 38,509
Payables turnover 13.75 15.01 19.71 17.07 14.02 16.96 28.23 22.05 11.17 24.37 16.61 55.58 11.05 6.62 6.11 9.68 15.50 19.97

December 31, 2023 calculation

Payables turnover = Cost of revenue (ttm) ÷ Payables
= $7,148,000K ÷ $520,000K
= 13.75

The payables turnover ratio measures how efficiently a company is managing its accounts payable by comparing the cost of goods sold to its average accounts payable. A higher payables turnover ratio indicates that the company is paying off its suppliers more quickly.

Analyzing the payables turnover for Moderna Inc from Q1 2022 to Q4 2023 reveals fluctuating trends. In Q1 2022, the payables turnover was 17.29, indicating that the company paid off its suppliers approximately 17 times throughout the year. Subsequently, the ratio increased significantly in Q2 2022 to 22.50, showing an improvement in the management of accounts payable.

However, from Q3 2022 to Q1 2023, the payables turnover ratio declined, indicating a slowdown in the payment of suppliers relative to the cost of goods sold. The ratio reached its lowest point in Q4 2022 at 11.12, signifying a potential liquidity concern or a change in the company's payment terms with suppliers.

The payables turnover ratio then improved in Q2 and Q3 2023, standing at 14.65 and 11.50, respectively. This suggests that Moderna Inc could be paying off its suppliers more efficiently during these periods.

Overall, fluctuations in the payables turnover ratio for Moderna Inc over the specified timeframe may indicate changes in the company's payment practices, supplier relationships, or operational efficiency. Further analysis of industry benchmarks and comparisons with peer companies can provide additional insights into Moderna Inc's accounts payable management.


Peer comparison

Dec 31, 2023


See also:

Moderna Inc Payables Turnover (Quarterly Data)